Private equity company acquisitions of nursing homes and assisted living facilities regulated, study required, and money appropriated.
HF2771 would create a new regulatory framework for private equity acquisitions of Minnesota nursing homes and assisted living facilities. The bill defines “private equity company” broadly, expands the definitions of “controlling person” and “controlling individual,” and requires advance notice to the attorney general, the commissioner of health, and the commissioner of human services at least 120 days before a transfer of ownership or control. Private equity buyers would have to submit extensive ownership, financial, operational, litigation, and facility-condition information, along with an affidavit showing they can operate the facility lawfully and responsibly.
The bill also bars a private equity company from acquiring a facility unless the attorney general, after consulting with health and human services officials, approves the deal. Approval would depend on findings that the transfer will not harm resident health or safety, raise costs unfairly, reduce quality, worsen maintenance, or cut staffing, and for nursing homes, that CMS star ratings will improve or at least not decline depending on the current rating. The bill further restricts post-acquisition conduct by prohibiting interference with clinical judgment, unequal treatment based on payment source, and asset stripping, while also limiting real estate investment trust arrangements, requiring a minimum share of public-program revenue to be spent on direct care, mandating severance for layoffs, and imposing ongoing reporting duties.
In addition to regulation, HF2771 directs the attorney general to investigate the effects of private equity ownership of nursing homes and assisted living facilities in Minnesota and report findings to legislative committees by February 15, 2026. The bill appropriates general fund money in fiscal year 2026 for that investigation. It also creates a conditional approval and receivership process for urgent situations, and allows denied applicants to appeal to the Office of Administrative Hearings.
The overall sentiment reflected in the bill text is strongly skeptical of private equity ownership in long-term care, with the legislation designed to slow, scrutinize, and potentially block acquisitions unless the buyer can affirmatively show resident protections. Because no committee transcript or vote record is provided, there is no recorded floor or committee debate to indicate support or opposition from specific lawmakers. The bill’s structure suggests its sponsors are concerned about staffing, affordability, facility upkeep, and quality of care under private equity ownership.
The main points of contention likely center on the breadth of the attorney general’s approval authority, the extensive disclosure and reporting requirements, and the operational limits placed on private equity firms and related real estate structures. Facility operators and investors may view the bill as overly restrictive or burdensome, while resident advocates and regulators would likely support the added oversight, direct-care spending requirements, and anti-asset-stripping provisions.
The bill would add a new chapter of law governing private equity ownership or control of nursing homes and assisted living facilities, while also amending existing definitions in the nursing home and assisted living statutes to broaden who counts as a controlling person or controlling individual. It would create a pre-acquisition review and approval process administered by the attorney general, impose ongoing reporting and spending requirements after acquisition, and authorize investigations, conditional approvals, appeals, and receivership-related actions. The bill would directly affect private equity firms, facility owners, residents, workers, and state oversight agencies, especially the attorney general, Department of Health, and Department of Human Services.
The bill appears generally protective of residents and skeptical of private equity involvement in long-term care. Its provisions emphasize oversight, transparency, staffing, affordability, and quality-of-care safeguards, indicating a policy concern that private equity acquisitions may negatively affect vulnerable residents. No committee discussion or vote history is available in the provided materials, so there is no recorded evidence of formal support or opposition beyond the bill’s text and sponsor framing.
Likely areas of contention include whether the attorney general should have veto power over acquisitions, whether the bill sets too high a bar for private equity buyers to prove financial and operational fitness, and whether the reporting and direct-care spending mandates are workable. Private equity firms and affiliated real estate or financing entities may object to the bill’s broad definitions, disclosure obligations, restrictions on REIT arrangements, and limits on post-acquisition business practices. Supporters would likely argue that these provisions are necessary to prevent cost increases, staffing cuts, asset stripping, and declines in care quality in nursing homes and assisted living facilities.